Cargando…
Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies
Background: The addition of dendritic cell vaccines (DCV) to NAC could induce immune responses in those patients with residual disease (RD) by transforming the tumor microenvironment. Methods: Core diagnostic biopsies and surgical specimens from 80 patients (38 in the vaccinated group plus NAC (VG)...
Autores principales: | Mejías Sosa, Luis, López-Janeiro, Álvaro, Córdoba Iturriagagoitia, Alicia, Sala, Pablo, Solans, Belén P., Hato, Laura, Inogés, Susana, López-Díaz de Cerio, Ascensión, Guillén-Grima, Francisco, Espinós, Jaime, De La Cruz, Susana, Lozano, María Dolores, Idoate, Miguel A, Santisteban, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953435/ https://www.ncbi.nlm.nih.gov/pubmed/36830775 http://dx.doi.org/10.3390/biomedicines11020238 |
Ejemplares similares
-
Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis
por: Santisteban, Marta, et al.
Publicado: (2021) -
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
por: Inogés, Susana, et al.
Publicado: (2017) -
A Quantitative Digital Analysis of Tissue Immune Components Reveals an Immunosuppressive and Anergic Immune Response with Relevant Prognostic Significance in Glioblastoma
por: Idoate Gastearena, Miguel A., et al.
Publicado: (2022) -
MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
por: Soldevilla, Mario Martínez, et al.
Publicado: (2016) -
C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d
por: Kowalska, Daria, et al.
Publicado: (2022)